The BSH Global Haematology Special Interest Group (SIG) are seeking a third Task Force member to collaborate on the BSH Plenary Speaker Scheme.
BSH is funding plenary speakers for haematology and transfusion conferences in low-to-middle income cou...
5 years ago
A drug for sickle cell disease is showing great promise in the early stages of its clinical trial, a conference has heard.
The first findings from the trial of the drug IMR-687 were reported to the European Haematology Association Congress in Amst...
5 years ago
